Measles vaccine: do we need new vaccines or new programs?

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMID 8073281)

Published in Science on September 02, 1994

Authors

S L Katz1, B G Gellin

Author Affiliations

1: Department of Pediatrics, Duke University Medical Center, Durham, NC 27710.

Articles by these authors

Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet (1989) 3.09

Analysis of clinical and food-borne isolates of Listeria monocytogenes in the United States by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Appl Environ Microbiol (1990) 2.90

Fungal infections: a growing threat. Public Health Rep (1996) 2.59

Association of sporadic listeriosis with consumption of uncooked hot dogs and undercooked chicken. Lancet (1988) 2.42

Analysis of Listeria monocytogenes by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Int J Food Microbiol (1989) 2.29

Characterization of Neisseria meningitidis serogroup C by multilocus enzyme electrophoresis and ribosomal DNA restriction profiles (ribotyping). J Clin Microbiol (1992) 1.49

Meningococcal disease in the United States--1986. Meningococcal Disease Study Group. J Infect Dis (1991) 1.34

Invasive Haemophilus influenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs. JAMA (2000) 1.18

Cardiac mortality in Alaska's indigenous and non-Native residents. Int J Epidemiol (1993) 1.16

The risk of vaccination--the importance of "negative" studies. N Engl J Med (2001) 1.04

Severity and frequency of sequelae of bacterial meningitis in Alaska Native infants. Correlation with a scoring system for severity of sequelae. Am J Dis Child (1992) 0.84

Global DTP manufacturing capacity and capability. Status report: January 1995. Vaccine (1996) 0.84

The bright spot about AIDS: it is very tough to catch. AIDS (1990) 0.80

Measles-mumps-rubella vaccine and autism: the rise (and fall?) of a hypothesis. Pediatr Ann (2001) 0.75

Challenges to vaccine safety. Prim Care (2001) 0.75